
11 - 50 employees
Founded 2015
💊 Pharmaceuticals
🧬 Biotechnology
Pharmaceuticals • Biotechnology
Achieve Life Sciences is a late-stage specialty pharmaceutical company focused on developing cytisinicline as a treatment for nicotine dependence (smoking and vaping cessation). The company is advancing cytisinicline through Phase 2 and Phase 3 ORCA trials and has submitted an NDA; its clinical program targets nicotinic receptors to reduce withdrawal and smoking satisfaction, with the goal of providing a new FDA-approved treatment option for tobacco and nicotine dependence.
Selected: 🆕 Date Added.
🕒 5 days ago
Director leading commercial data strategy, governance, analytics, and launch readiness for Achieve Life Sciences’ cytisinicline commercialization. Building scalable data operations across pharmaceutical partners and stakeholders.